1066

Dr Srikanth Murali Krishnan

Oncology
25+ Years  experience
MBBS, MD, MRCP(UK), FRCPath(UK), Dip RCPath (UK), CCT(UK), Heamatology
10:00 -15:30  •  Mon - Sat English  •  Hindi  •  Telugu  •  Tamil

DOCTOR UNAVAILABLE

No Slots Available. Please request a call back

Select Date

    > Loading available days...

Available Slots:

    Overview

    Dr. Srikanth Murali Krishnan is a highly qualified and experienced Haematologist based in Chennai, Tamil Nadu. With an impressive 25 years of expertise in the field of haematology, Dr. Srikanth has earned a reputation as a trusted medical professional dedicated to providing exceptional patient care. He has successfully completed his MD, followed by prestigious international qualifications, including MRCP (UK), FRCPath (UK), Dip RCPath (UK), and CCT (UK) in Haematology. His extensive academic background reflects his commitment to continuous learning and excellence in diagnosing and treating various blood disorders. Fluent in English, Hindi, Telugu, and Tamil, Dr. Srikanth ensures effective communication with a diverse range of patients, helping them feel comfortable and well-informed throughout their treatment. His practice at Apollo Hospitals Greams Road, Chennai, is a testament to his dedication to delivering comprehensive and advanced haematological care. Dr. Srikanth specializes in diagnosing and managing a wide spectrum of blood-related conditions, offering personalized treatment plans tailored to each patient’s unique needs. He combines cutting-edge medical advancements with compassionate care, ensuring the best possible outcomes for his patients. As a valued member of the Apollo team, Dr. Srikanth Murali Krishnan remains committed to staying at the forefront of haematology, continuously updating his knowledge and expertise. His goal is to improve the quality of life for his patients, providing them with effective treatment options and guidance toward better health and well-being.

    Apollo Hospitals, Greams Road, Chennai
    Apollo Hospitals 21, Greams Lane, Off Greams Road Chennai 600 006 Ph:044-28290200/3333, Chennai, TN, 600006

    Experience

    • I HAVE UNDERGONE MY POST GRADUATE, SPECIALIST, SUPER SPECIALIST AND RESEARCH TRAINING IN UK AND HAVE BEEN PRACTISING IN UK AS SENIOR CONSULTANT IN HAEMATOLOGY AND HAEMATO- ONCLOGY OVER A PERIOD OF 25 YEARS IN PREMIERE INTERNATIONAL INSTITUTION WHICH INCLUDE
    • ROYAL MARSDEN HOSPITAL
    • ST GEORE HEALTH CARE LONDON
    • HAMMERSMITH HOSPITAL LONDON
    • INSTITUTE OF CANCER RESEARCH UK

    Memberships

    • AMERICAN SOCIETY OF HAEMATOLOGY
    • ROYAL COLLEGE OF PATHOLOGIST UK
    • BRITISH SOCIETY OF HAEMATOLOGY
    • EUROPEAN SOCIETY OF HAEMATOLOGY
    • ROYAL COLLEGE OF PHYSICIANS UNITED KINGDOM

    Research and Publication

    Publications:

    • Srikanth M,  Jenner M, Wu  P, Kaczmarek P, Dines S, Saso RM, Ethell M,  M Potter M, Treleaven JG, Davies FE, Morgan GJ  Survival and Outcome of Blastoid Variant Myeloma Following Treatment with DT-PACE.Haematologica .2007;92:712.
    • Morgan GJ, Schey SA, Wu P, Srikanth M, Phekoo KJ, Jenner M, Davies FE. Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients. Br J Haematol. 2007;137:268-9.
    • Davies FE, Wu P, Jenner M, Srikanth M, Saso R, Morgan GJ.  The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone. Haematologica 2007;92:1149-50.
    • Davies FE, Srikanth M, Wu P, Jenner M,  McCormack R,  Cordero F, Trudel G, Morgan GJ. The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant clinical activity in relapsed/refractory myeloma patients.  Blood 2007;110:2727.
    • Srikanth M, Davies F E, Morgan GJ. Update on novel drug combinations in Multiple Myeloma. Expert opinion on Investigational Drugs. 2008;17:1-12.
    • Moore HE, Davenport EL, Smith EM, Muralikrishnan S, Dunlop AS, Walker BA, Krige D, Drummond AH, Hooftman L, Morgan GJ, Davies FE. Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma. Molecular Cancer Therapy,2009:762-770.
    • Aronson L, Davenport EL, Giuntoli SG, Srikanth M, Smith E, Morgan GJ, Davies FE.
    • Autophagy is a key myeloma survival pathway  that can be manipulated therapeutically to enhance apoptosis. Blood 2010: 408

    Research: 

    • PERFORMED AT THE INSTITUTE OF CANCER RESEARCH UK AND ROYAL MARSDEN HOSPITAL LONDON UK.
    • EFFECT OF PI3 KINASE INHIBITION IN MULTIPLE MYELOMA .
    • PHASE 1 AND DRUG DEVELOPMENT IN MULTIPLE MYELOMA.

     

    Special Interests

    • MULTIPLE MYELOMA
    • LEUKEMIAS
    • LYMPHOMAS
    • ITP
    • CML

    Conditions and Procedures

    Aplastic anemia
    Paroxysmal Nocturnal Hemoglobinuria
    Hereditary Pyropoikilocytosis
    Anemia
    Bernard Soulier Syndrome
    Thalassaemia
    Burkitt Lymphoma
    Hemophilia
    Polycythemia vera
    Hemolytic Anemia
    Hermansky Pudlak Syndrome
    Sideroblastic Anemia
    Blood Cancer
    Glanzmann Thrombasthenia
    Hereditary Spherocytosis
    Blood Disorders

    Frequently Asked Questions

    Where does Dr. Srikanth Murali Krishnan practice?

    Dr. Srikanth Murali Krishnan currently practices at Apollo Hospitals, Greams Road, located in Chennai.

    Who is Dr. Srikanth Murali Krishnan?

    Dr. Srikanth Murali Krishnan is a highly experienced Haematologist with over 25 years of expertise in the field. He is known for providing exceptional patient care and advanced medical treatments. He areas of expertise include Blood Transfusions, Bone Marrow Transplant. He also treats conditions such as Anemia, Hemophilia.

    Why do patients choose Dr. Srikanth Murali Krishnan?

    Patients trust Dr. Srikanth Murali Krishnan for he expertise, patient-centric approach, and commitment to providing the highest standard of care. He is well-versed in the latest medical advancements and ensures personalized treatment for every patient.

    What is Dr. Srikanth Murali Krishnan’s specialization?

    Dr. Srikanth Murali Krishnan specializes in Haematology, with expertise in treatments for Blood Transfusions, Bone Marrow Transplant.

    What are Dr. Srikanth Murali Krishnan’s medical qualifications?

    Dr. Srikanth Murali Krishnan holds prestigious qualifications, including MBBS, MD, MRCP(UK), FRCPath(UK), Dip RCPath (UK), CCT(UK), Heamatology

    How many years of experience does Dr. Srikanth Murali Krishnan have?

    Dr. Srikanth Murali Krishnan has over 25 years of experience in the medical field, treating various conditions related to Haematology.

    How can I book an appointment with Dr. Srikanth Murali Krishnan?

    You can book an appointment with Dr. Srikanth Murali Krishnan through:
    Online: Visit https://www.apollohospitals.com/book-doctor-appointment/ to schedule an appointment.

    Could not find what you are looking for? 

    Request a Callback

    Image
    Image
    Request A Call Back
    Request Type

    Need Medical Help? 

    Submit your details and our care expert will call you within 2 minutes.

    popup